Funding Opportunities
Internal and external funding opportunities collected by the CTSI.
CTSI PilotsThe Translational Pilot Program will solicit, review and award pilot grants designed to produce and test novel tools and methods to bridge translational gaps. |
Ignition FundsProviding ignition funding to accelerate progress for clinical and translational research projects. |
K12 FundingProving 2-3 years of support for early-career research faculty from Wake Forest. |
Community-Engaged Research FellowshipFinancial support for representatives from community organizations and WF investigators to build a community-engaged research partnership. |
Special Populations Voucher FundsStudies that identify a financial need can request funds from the voucher program to help overcome barriers related to transportation, child care, etc. |
Internal
Recurring Funding Opportunities:
- CTSI - Translational Pilot Program Ignition Funds - Deadline: 10/01/24
- CTSI - Research Salary Bridge Funding - Deadline: 10/01/24
- CTSI - Early Career Salary Support - Deadline: 10/01/24
School of Medicine and Advocate Health 2024 Requests For Proposals
The WFU Program for Leadership and Character invites proposals from any WFU School of Medicine or AHWFB or Advocate Health System employee with ideas for character development programs for current and/or future clinicians (i.e. students) and/or care team members. The Program has two RFPs :
Character in Medicine (Small to Medium Projects Now):
• $1-$30K
• Quick application (30 minutes)
• Funds available from now until August 2025
• Applications accepted on a rolling basis
• Contact Elizabeth Whiting or Lauren Iley-Spear
Character in Health Systems (Big Ideas Projects in 2026-2031):
• Welcome ideas for projects between $1000 and $5 million
• Quick application (20 minutes), the Program will follow up with strong applications for more details.
• Funding available starting in early 2026
• Applications due by August 31, 2024
• Contact Elizabeth Whiting
AHWFBCCC Intercampus Cancer Research Pilot RFA
Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AHWFBCCC) is pleased to announce the availability of funds to support new or ongoing inter-campus collaborative research that include investigators from two or more AHWFBCCC campuses and has promise for larger-scale extramural support. This pilot project opportunity is available to all AHWFBCCC members or non-members who wish to collaborate with a member investigator as the PI/Co-PI.
Projects that highlight the “value-added” aspects across all campuses of AHWFBCCC, such as a focus on translational research, inclusion of investigators from more than one of the four scientific research programs (inter-programmatic), use of AHWFBCCC Shared Resources, and new investigator teams will be prioritized. Projects that can lead to multi-PI extramural grant applications (R01s, P01s and SPOREs) as well as inter-institutional (i.e., with external institutions) collaborations are encouraged.
Visit the AHWFBCCC 2024 Funding Opportunities Redcap form to learn more about eligibility and the RFA guidelines, or to submit an application.
Applications are due Monday, October 14, 2024, at 5:00pm EST.
AHWFBCCC Tobacco Control Center of Excellence 2024 Pilot RFA
The Atrium Health Wake Forest Comprehensive Cancer Center (AHWFBCCC) Tobacco Control Center of Excellence (TCCOE) is pleased to announce the availability of funds to support new innovative pilot research related to nicotine and tobacco, and with a clear path to support future extramural grant applications. This funding opportunity is available to all AHWFBCCC TCCOE Investigators, AHWFBCCC members as well as non-members who are willing to collaborate with TCCOE Investigators.
The pilot grant program aims to:
• Create new interdisciplinary teams of investigators working on nicotine and tobacco research, using team science approaches to address the critical areas challenging the field.
• Support early career faculty.
• Increase the number and quality of external grants submitted and funded related to nicotine & tobacco.
Visit the AHWFBCCC 2024 Funding Opportunities Redcap form to learn more about eligibility and the RFA guidelines, or to submit an application.
Applications are due Monday, October 14, 2024, at 5:00pm EST.
CDOM Ignition Funds
The Center for Diabetes, Obesity and Metabolism is seeking proposals related to the broad areas of diabetes, obesity and metabolism. Projects can span the translational spectrum from issues that deal with populations, clinical science and basic science. We are particularly interested in supporting projects in the realms of outcomes, prevention and population health.
Funds will be awarded for up to $5,000 to be spent within a maximum of 3 months from the date of award. One project will be awarded every two months, totaling six projects awarded each calendar year. The RFA is available here. Please contact Katelyn Still with questions.
To apply, click here. Application deadlines for the remainder of 2024 are: October 1 and December 3.
Center for Remote Health Monitoring Pilot Studies Research Program
The Center for Remote Health Monitoring is seeking proposals for pilot projects that involve the use of remote patient monitoring technologies to improve patient outcomes and study human health. Pilot projects are funded up to $40,000 that pursue new and inventive ideas involving wearable and mobile technologies. Projects can include deployment of those technologies in prospective studies or retrospective analysis of existing remote monitoring data.
These awards are open to investigators with faculty rank across Advocate Health. This includes Atrium Health, Atrium Health Navicent, and Atrium Health Wake Forest Baptist, including Wake Forest University School of Medicine.
Deadlines:
Letter of Intent: Friday, October 18, 2024 by 5:00PM EST
Notify Applicants: Monday, November 4, 2024
Full Application Deadline: Friday, December, 13, 2024 by 5:00PM EST
For more information, click here to view the RFA. To apply, click here.
2025 CTSI Pilot RFAs Now Open
The 2025 CTSI Pilot Awards are now open. The CTSI Pilot Program has two (2) distinct RFAs:
The Science of Translation and Translational Research.
- The Science of Translation RFA is to support new and innovative research projects relevant to the science of translation. These pilot projects must be focused on advancing translational science and not just be translational in nature. More information and resources about translational science can be found on the CTSI Pilot Program webpage and in the RFA.
- The Translational Research RFA is to support high impact pilot projects that help catalyze translation of discoveries to treatments or the delivery of care. Pilot award categories for this RFA include Basic Research, Preclinical Research, Clinical Research, Clinical Implementation and Public Health. More information can be found in the RFA.
Deadlines:
- Letter of Intent: Friday, October 11, 2024, 11:59PM ET
- Investigators Invited for Full Application: Tuesday, November 12, 2024
- Full Application Due:Friday, December 13, 2024, 11:59PM ET
- Project Start Date: Tuesday, July 1, 2025
Research Centers
An Institutionally-Supported Research Center is an interdepartmental unit focused predominantly on translational, clinical and/or basic science research which facilitates development of a common, focused research agenda aligned with strategic priorities, coordinating contributions from multiple disciplines (other centers, divisions/departments, and programs). We are pleased to announce the following opportunities are now available:
Research Centers – The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Research Center. This document also provides the framework for a renewal application of an existing center. Research Centers support mature areas of research that reflect depth in translational, clinical and/or basic science research. View the full RFA for Research Centers here.
Emerging Research Centers - The purpose of this RFA is to invite applications to develop an Institutionally-Supported Advocate Health/Wake Forest University School of Medicine Emerging Research Center. This document also provides the framework for a renewal application of an existing center. Emerging Research Centers support new ideas in need of investment for growth. The investment is intended to catalyze the formation of a team for the specific purpose of developing a strategic vision in order to grow a critical base of extramurally funded research. This research can be established in translational, clinical and/or basic science research. View the full RFA for Emerging Research Centers here.
Direct questions and applications to Lynne Wagenknecht, Vice Dean for Population Health Research, and/or Lindsay Trost, CTSI Administrative Director.
Foundation
Interested applicants may contact the Foundations Relations team at foundations@wakehealth.edu.
| Cancer, Pediatrics | Andrew McDonough B+ Foundation | Childhood Cancer Research Grant |
$150,000 | 9/3/2024 |
| Gastroenterology | Kenneth Rainin Foundation | Collaborative Innovator Award LOI |
$300,000 | 9/30/2024 |
| Varied | Burroughs Wellcome Fund | Career Awards for Medical Scientists |
$700,000 | 10/8/2024 |
Errett Discovery Award
In honor of Daryl and Marguerite Errett, the Errett Fisher Foundation will fund The Daryl and Marguerite Errett Discovery Award. This award will provide support for one Winston-Salem based outstanding postdoctoral fellow or early career faculty member annually so as to enable him/her to conduct leading edge research in biomedicine and launch promising projects that nurture the careers of gifted young investigators who will have an impact on pioneering developments that advance human health.
This $75,000 award is intended to supply seed funding to outstanding scientists who seek to conduct risk-taking research that may not yet qualify for traditional sources of funding as an independent investigator from agencies like the National Institutes of Health. Faculty are not eligible if they are located outside of Winston-Salem, or are a principal investigator on an NIH award or other independent faculty awards; however, early career funding mechanisms from foundations and industry are acceptable. This may include funding from NIH such as K-Awards, American Heart Association, etc.
Department Chairs and Section Heads are invited to nominate their most outstanding postdoctoral fellows or early career faculty members located in Winston-Salem, who have the potential to conduct leading-edge research in the biomedical research field. More than one nomination is allowed.
Interested applicants should follow the RFA instructions and submit their electronic application by Friday, September 13, 2024.
W. M. Keck Foundation
The W. M. Keck Research Program seeks to benefit humanity by supporting Medical Research projects that are distinctive and novel in their approach, question the prevailing paradigm, or have the potential to break open new territory in their field. The Research Program employs a two-phase application process with optional pre-application counseling. All communication with the foundation, including submitting applications, proposals and reports must be via the institution’s designated liaison, the Corporate & Foundation Relations team in the Office of Philanthropy.
Click here for RFA details. This opportunity is open to those with a WFSOM faculty designation. Questions regarding the application process should be directed to Joanna Yu, JD. Concept papers should be emailed to Ellen Alexander. Concept paper deadline is October 18, 2024 at 11:59PM EST.
NIH
- RFA-AG-24-039: Development and Validation of Harmonized Methodologies to Measure NAD+ and Related Metabolites in Clinical Trials (U01 Clinical Trial Required)
- PAR-23-240: Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
Professional Associations and Societies
Please refer to the individual Program or Funding Opportunity Announcement for deadline information.
- American Cancer Society
- The Triological Society
- American Heart Association
- American Gastroenterological Association
- American Federation for Aging Research
- Alzheimer's Association
- ALS Association
- American Diabetes Association
- Juvenile Diabetes Research Foundation
- Thoracic Surgery Foundation for Research and Education
- Society for Pediatric Dermatology
Other Opportunities
All of Us Research Program
All of Us Research Program Seeks Engagement and Enrollment Partners: The National Institutes of Health's All of Us Research Program has issues a new funding opportunity soliciting proposals to support outreach, community engagement and participant enrollment and retention efforts. The opportunity spans four specific areas of interest, including community, participant and health care provider engagement, enrollment and retention; researcher engagement; Tribal engagement; and integration of participants and advocates in program oversight.
• Proposals will be accepted on an ongoing basis through May 23, 2025
• Read the Full Announcement
ARPA-H Launches Program to Develop at-home Multi-Cancer Screening Test
POSEIDON - Platform Optimizing SynBio for Early Intervention and Detection in Oncology - aims to fundamentally change the field of cancer screening by developing first-in-class, over-the-counter, Multi-Cancer Early Detection (MCED) tests that screen for 30+ cancers at Stage 1. POSEIDON intends to develop non-invasive synthetic sensors and reporters to reliably detect cancer from breath or urine samples at home. The self-administered kit, based on human-centered design, would allow any adult American to screen for cancers before symptoms arise. The kit would also integrate results securely with electronic health records and ensure individuals connect with a health care professional via a telemedicine call to review results.
For more information about this opportunity or the in-person Proposers' Day on September 4th in Baltimore, MD, please visit the website or contact the Program Manager, Ross Uhrich, DMD, MBA.
Leukemia and Lymphoma Society
The Leukemia & Lymphoma Society (LLS) announced the opening of its application process for the 2025 funding cycle under their Equity in Access Research Program. Researchers are invited to submit Letters of Intent for studies that align with the topic of “Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups.” Awards will be a maximum of $2.5 million each, over 5 years with a grant start date of July 1, 2025.
LLS is particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation. It is not necessary for applicants to have previously conducted research in blood cancer.
The due date for Letters of Intent is September 12, 2024, at 3:00 pm ET. You can find more information and the RFP details here. Click here to email with questions about this RFP and the application process.
NeuroNEXT Grant
The NeuroNEXT Network is designed to efficiently conduct Phase II Clinical Trials. NeuroNEXT Network is now accepting proposals. Applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies are encouraged. Successful applicants will be given access to the NeuroNEXT infrastructure to support the efficient implementation of the proposed study at multiple sites and statistical and data management.
If you are interested, please schedule a meeting to discuss your proposal with the NeuroNEXT Study Team. This opportunity is ongoing until 2028.
- Benefits of Partnering with NeuroNEXT
- Applying for a NeuroNEXT Grant
- Contact: Mysha Sissine, Program Manager
PCORI Opportunities
PCORI Rare Disease Research Funding: A new topical PCORI PFA seeks to fund high-quality patient-centered CER projects that focus on rare diseases. Application deadline: September 4, 2024 at 5PM ET.
PCORI Phased Research Funding: This PCORI PFA invites applications for high-quality patient-centered CER projects that will address critical decisions faced by patients, families, caregivers, clinicians, and the health and healthcare community and for which there is insufficient evidence. Application deadline: September 4, 2024 at 5PM ET.
PCORI Funding for Research that Improves CER Methods: With this PCORI PFA, PCORI aims to fund studies that address high-priorty methodological gaps in patient-centered CER. Application deadline: September 4, 2024 at 5PM ET.
Additional Resources
Listed below are some quick ways to find external funding opportunities through search mechanisms and announcement listservs.
Additional Resources
- For detailed information on funding opportunities, search www.grants.gov with keywords related to your research interests.
- National Institutes of Health (NIH)
- NIH Career Development Awards (K-Series)
- Patient-Centered Outcomes Research Institute (PCORI)
- Health Resources and Services Administration (HRSA)
- National Science Foundation (NSF)
- North Carolina Biotechnology Center